Ocular Therapeutix, Inc. (OCUL)
9.82
+0.96
(+10.84%)
USD |
NASDAQ |
Apr 17, 16:00
9.70
-0.12
(-1.22%)
After-Hours: 06:57
Ocular Therapeutix SG&A Expense (Quarterly) : 30.62M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| EyePoint, Inc. | 11.38M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Vertex Pharmaceuticals, Inc. | 487.00M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Rhythm Pharmaceuticals, Inc. | 57.48M |